COMBINED contraceptives carry a
very rare risk of blood clots, and
the risk differs between types of
combined contraceptives,
according to the European
Medicines Agency.
The comments come in response
to growing reports in the media
about combined contraceptives
and venous thromboembolism.
“There is currently no new
evidence that would suggest any
change to the known safety profile
of any combined contraceptives
marketed today,” the EMA said.
“Therefore, there is no reason for
any woman to stop using her
contraception,” the EMA added.The above article was sent to subscribers in Pharmacy Daily's issue from 15 Jan 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Jan 13
MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.
PHARMACIES in regional areas need a restructure of the 8CPA Community Service Obligation (CSO) to help fund them to support their workforce and deliver services, says the Remote and Isolated Pharmacist Association Australia (RIPAA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.